COVID-19 therapeutics for children: Where are we now, and how did we get here?
October 10th 2022In a session at the 2022 AAP National Conference & Exhibition, a physician presenter enumerates unique challenges in treating emerging infectious diseases in children and takes a look at the current pediatric COVID-19 therapies—and evidence gaps.
COVID-19 in children: medication and vaccine dosing, safety, and regulatory considerations
October 9th 2022At the 2022 AAP National Conference & Exhibition, one session reviews pediatric considerations for dosing, safety, and regulatory approval for medications and vaccines for SARS-CoV-2, and a look at the Pediatric Trials Network.
Antimicrobial update: optimizing prescribing for common infections
October 8th 2022At the 2022 AAP National Conference & Exhibition in Anaheim, California, Rana E. El Feghaly, MD, MSCI, associate professor, University of Missouri-Kansas City, Children's Mercy Kansas City, Missouri, led a session on how pediatric clinicians can employ best practices when prescribing medications for common childhood infections.
Provocative poster sessions abound at the SPD 2022 47th Annual Meeting
July 3rd 2022You will find dermatologic studies from the rare (annual erythema of infancy) to the common (atopic dermatitis) and lots in between at the poster sessions at this year's SPD 2022 47th Annual Meeting in Indianapolis, Indiana.
How do pediatricians help patients cope with yet another school shooting?
May 25th 2022Contemporary Pediatrics weighed in with Editorial Advisory Board member Emily Aron, MD, a child, adolescent, and adult psychiatrist affiliated with MedStar Georgetown University Hospital in Washington, DC, about how pediatricians can guide parents in discussing traumatic events like the May 24, 2022 Robb Elementary School Shooting in Uvalde, Texas.